PROCEPT BioRobotics (PRCT) Stock Price Target 2026

The average analyst price target for PROCEPT BioRobotics is $32.54, 58.2% above the current price. Of 14 analysts, 6 rate it Buy, 7 Hold and 1 Sell. Targets range from $20 to $95. The latest change came on Nov 6, 2026, when Truist Securities raised its price target on PROCEPT BioRobotics from $21 to $24 and kept a Hold rating.

The Average Analyst Price Target for PROCEPT BioRobotics is $32.54.

Price Target Range — 13 Quarters

Analyst Consensus — 14 Analysts

6Buy

7Hold

1Sell

Consensus RatingOverweight# Analysts14Avg. Consensus PT$32.54Upside to Avg. PT+58.2%

Rating Trend — Last 9 Months

Latest Upgrades and Downgrades for PROCEPT BioRobotics Stock

See all ratings →

Date	Firm	Analyst	Action	Rating Change	Price Target
Nov 6, 2026	Truist Securities	Richard Newitter	PT Raise	Hold	$21→$24
Nov 5, 2026	UBS	Patrick Wood	PT Raise	Neutral	$20→$21
Nov 5, 2026	Leerink Partners	Mike Kratky	PT Raise	Market Perform	$20→$22
Oct 7, 2026	Barclays	Christopher Pasquale	Initiate	Overweight	$30
Aug 5, 2026	TD Cowen	Joshua Jennings	PT Cut	Buy	$34→$28
Aug 5, 2026	Piper Sandler	Matt O'Brien	PT Cut	Overweight	$35→$25
Aug 5, 2026	Evercore ISI Group	Vijay Kumar	PT Cut	Outperform	$30→$23
Aug 5, 2026	William Blair	Brandon Vazquez	Downgrade	Outperform→Market Perform	—
Jul 28, 2026	UBS	Danielle Antalffy	Assumes	Buy→Neutral	$20
Jul 6, 2026	Truist Securities	Richard Newitter	Downgrade	Buy→Hold	$30→$25
Jun 24, 2026	Evercore ISI Group	Vijay Kumar	Initiate	Outperform	$30
Jun 11, 2026	Leerink Partners	Mike Kratky	Downgrade	Outperform→Market Perform	$31→$29
Apr 30, 2026	Piper Sandler	Matt O'Brien	PT Raise	Overweight	$28→$35
Mar 6, 2026	Baird	David Rescott	Initiate	Neutral	$30
Mar 2, 2026	Truist Securities	Richard Newitter	PT Cut	Buy	$47→$30
Feb 26, 2026	Leerink Partners	Mike Kratky	PT Cut	Outperform	$55→$30
Feb 26, 2026	TD Cowen	Joshua Jennings	PT Cut	Buy	$50→$34
Feb 26, 2026	Oppenheimer	Suraj Kalia	Downgrade	Outperform→Perform	—
Feb 26, 2026	Piper Sandler	Matt O'Brien	PT Cut	Overweight	$50→$28
Feb 26, 2026	Wells Fargo	Nathan Treybeck	PT Cut	Overweight	$51→$34

Analyst Ratings News

PRO
Truist Securities Maintains Hold on PROCEPT BioRobotics, Raises Price Target to $24

Truist Securities analyst Richard Newitter maintains PROCEPT BioRobotics (NASDAQ:PRCT) with a Hold and raises the price target from $21 to $24.

Benzinga Newsdesk

PRO
UBS Maintains Neutral on PROCEPT BioRobotics, Raises Price Target to $21

UBS analyst Patrick Wood maintains PROCEPT BioRobotics (NASDAQ:PRCT) with a Neutral and raises the price target from $20 to $21.

Benzinga Newsdesk

PRO
Leerink Partners Maintains Market Perform on PROCEPT BioRobotics, Raises Price Target to $22

Leerink Partners analyst Mike Kratky maintains PROCEPT BioRobotics (NASDAQ:PRCT) with a Market Perform and raises the price target from $20 to $22.

Benzinga Newsdesk

PRO
Barclays Initiates Coverage On PROCEPT BioRobotics with Overweight Rating, Announces Price Target of $30

Barclays analyst Christopher Pasquale initiates coverage on PROCEPT BioRobotics (NASDAQ:PRCT) with a Overweight rating and announces Price Target of $30.

Benzinga Newsdesk

PRO
TD Cowen Maintains Buy on PROCEPT BioRobotics, Lowers Price Target to $28

TD Cowen analyst Joshua Jennings maintains PROCEPT BioRobotics (NASDAQ:PRCT) with a Buy and lowers the price target from $34 to $28.

Benzinga Newsdesk

PRO
Piper Sandler Maintains Overweight on PROCEPT BioRobotics, Lowers Price Target to $25

Piper Sandler analyst Matt O'Brien maintains PROCEPT BioRobotics (NASDAQ:PRCT) with a Overweight and lowers the price target from $35 to $25.

Benzinga Newsdesk

PROCEPT BioRobotics Corp

PROCEPT BioRobotics (PRCT) Stock Price Target 2026

The Average Analyst Price Target for PROCEPT BioRobotics is $32.54.

Latest Upgrades and Downgrades for PROCEPT BioRobotics Stock

Analyst Ratings News

PRO
Truist Securities Maintains Hold on PROCEPT BioRobotics, Raises Price Target to $24

PRO
UBS Maintains Neutral on PROCEPT BioRobotics, Raises Price Target to $21

PRO
Leerink Partners Maintains Market Perform on PROCEPT BioRobotics, Raises Price Target to $22

PRO
Barclays Initiates Coverage On PROCEPT BioRobotics with Overweight Rating, Announces Price Target of $30

PRO
TD Cowen Maintains Buy on PROCEPT BioRobotics, Lowers Price Target to $28

PRO
Piper Sandler Maintains Overweight on PROCEPT BioRobotics, Lowers Price Target to $25

People Also Watch

People Also Watch

PROCEPT BioRobotics Corp

PROCEPT BioRobotics (PRCT) Stock Price Target 2026

The Average Analyst Price Target for PROCEPT BioRobotics is $32.54.

Latest Upgrades and Downgrades for PROCEPT BioRobotics Stock

Analyst Ratings News

PROTruist Securities Maintains Hold on PROCEPT BioRobotics, Raises Price Target to $24

PROUBS Maintains Neutral on PROCEPT BioRobotics, Raises Price Target to $21

PROLeerink Partners Maintains Market Perform on PROCEPT BioRobotics, Raises Price Target to $22

PROBarclays Initiates Coverage On PROCEPT BioRobotics with Overweight Rating, Announces Price Target of $30

PROTD Cowen Maintains Buy on PROCEPT BioRobotics, Lowers Price Target to $28

PROPiper Sandler Maintains Overweight on PROCEPT BioRobotics, Lowers Price Target to $25

People Also Watch

People Also Watch

PRO
Truist Securities Maintains Hold on PROCEPT BioRobotics, Raises Price Target to $24

PRO
UBS Maintains Neutral on PROCEPT BioRobotics, Raises Price Target to $21

PRO
Leerink Partners Maintains Market Perform on PROCEPT BioRobotics, Raises Price Target to $22

PRO
Barclays Initiates Coverage On PROCEPT BioRobotics with Overweight Rating, Announces Price Target of $30

PRO
TD Cowen Maintains Buy on PROCEPT BioRobotics, Lowers Price Target to $28

PRO
Piper Sandler Maintains Overweight on PROCEPT BioRobotics, Lowers Price Target to $25